Oxidative stress in heart failure: what are we missing? - PubMed (original) (raw)

Review

Oxidative stress in heart failure: what are we missing?

Douglas B Sawyer. Am J Med Sci. 2011 Aug.

Abstract

Over the past several decades, investigations in humans and animal models of heart failure (HF) have provided substantial evidence that oxidative stress is increased in HF and contributes to disease progression. The high metabolic activity of cardiac myocytes makes these cells active sources of reactive oxygen species. Work in cell and animal models clearly demonstrates that oxidative stress activates processes such as changes in gene expression and cell death that are now accepted components of myocardial remodeling and HF. Antioxidants prevent progressive remodeling and even improve cardiac function in animal models of HF. It is therefore disappointing that to date no antioxidant strategy has translated to a therapeutic in the HF clinic. Possible explanations, including inadequate appreciation of the critical disease-modifying sources of reactive oxygen species, the choice of the wrong antioxidant strategy, or incomplete understanding of individual variability in human antioxidant defenses in this brief review.

PubMed Disclaimer

References

    1. Sam F, Kerstetter DL, Pimental D, et al. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail. 2005 in press. - PubMed
    1. Tsutsui H, Ide T, Kinugawa S. Mitochondrial oxidative stress, DNA damage, and heart failure. Antioxid Redox Signal. 2006;8(9–10):1737–44. - PubMed
    1. McMurray J, McLay J, Chopra M, et al. Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. 1990;65(18):1261–62. - PubMed
    1. Campolo J, Caruso R, De Maria R, et al. Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin. J Cardiovasc Med (Hagerstown) 2007;8(12):1024–8. - PubMed
    1. Tang WH, Brennan ML, Philip K, et al. Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol. 2006;98(6):796–9. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources